ISRG
Intuitive Surgical
Data as of 2026-10-14
Company attributes
Price
Interactive 5-year price history chart for ISRG. Latest close $427.64.
Pillar breakdown
0–100 percentile rank against the current universe (sector-relative for Quality / Value / Growth / Profitability)
- QualityProfit margins & asset efficiency71ExceptionalHealth Care median (n=163) 51
- ValuePrice vs fundamentals20PoorHealth Care median (n=163) 52
- GrowthRevenue & earnings trajectory72ExceptionalHealth Care median (n=163) 50
- MomentumRecent price strength19PoorHealth Care median (n=163) 66
- HealthBalance sheet & solvency76ExceptionalHealth Care median (n=163) 56
- ProfitabilityROE, ROA, ROIC75ExceptionalHealth Care median (n=163) 49
- TechnicalTrend & volatility signals53AverageHealth Care median (n=163) 57
- RiskVolatility & drawdown profile40AverageHealth Care median (n=163) 47
Pillars not shown: Sentiment, ML (Phase 5+).
Fair price check
4 different valuation methods each estimate what ISRG should be worth, then we compare to today's price.
- P/E multiplesOvervaluedthinks it's expensive — estimates $243.90, about 43% below today
- P/B multiplesOvervaluedthinks it's expensive — estimates $152.36, about 64% below today
- Graham (defensive)Outlierestimate looks unreliable — estimates $84.45 — likely unreliable
- Residual IncomeOutlierestimate looks unreliable — estimates $58.95 — likely unreliable
How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.
Fair price ensemble
- Median fair
- $118.41
- Margin of safety(vs fair value)
- < −99%
- Max (ex-outliers)
- $243.90
- Tangible BVPS
- $49.22
- Extreme Graham estimate
- Extreme Residual-Income estimate
Median of all applicable methods (current price $427.64). Per-method estimates + each method’s cheap/fair/pricey read are in the Fair price check above. Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.
Defense layer. Flags mark elevated risk, never confirmed fraud. This model cannot catch every manipulation and decays after publication — weigh it against its stated error rates.
Supporting dataRaw fundamentals & data-quality provenance behind the scores above
Raw fundamentals (SEC EDGAR)
| Metric | Value |
|---|---|
| Market cap | $151.08B |
| Revenue (TTM) | $11.03B |
| Net income (TTM) | $3.16B |
| Operating cash flow (TTM) | $3.71B |
| CapEx (TTM) | $483.80M |
| Free cash flow (TTM)CFO − CapEx | $3.22B |
| Total assets | $20.88B |
| Total liabilities | $2.58B |
| Stockholders' equity | $18.17B |
| Cash & equivalents | $2.76B |
| Shares outstanding | 353.28M |
| EPS (basic) | $8.94 |
| EPS (diluted) | $8.94 |
| P/E ratio (TTM) | 47.84 |
TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).
Data quality
- Latest filed date
- 2026-07-21
- Latest period end
- 2026-07-16
- Filing lag
- 85 days
- Missing metrics
- 6(depreciation_and_amortization, interest_expense, dividends_paid, long_term_debt, short_term_debt, ebitda)
Composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars are reserved for a later phase; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.